Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Update of the NCI multiinstittutional phase II trial of romidepsin, FK228, for patients with cutaneous or peripheral T-cell lymphoma

Piekarz R, Frye R, Wright J, Figg W, Allen S, Kirschbaum M, Zain J, Hutchins LF, Showe L, Fojo T, Bates SE. Update of the NCI multiinstittutional phase II trial of romidepsin, FK228, for patients with cutaneous or peripheral T-cell lymphoma. 2007.